Tumor necrosis factor gene promoter polymorphism and recurrent hepatitis C after liver transplantation: The missing link to pathogenesis or a casual association?

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 381-383

  Zein, Nizar N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ALLELE; CLINICAL ARTICLE; DISEASE SEVERITY; DNA POLYMORPHISM; FOLLOW UP; HUMAN; HYPOTHESIS; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MARKER GENE; NOTE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0034085978     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1527-6465(05)80024-3     Document Type: Article

References (36)

1. Seaberg E.C. Belle S.H. Beringer K.C. Schivins J.L. Detre K.M. Liver transplantation in the United States from 1987–1998: Updated results from the Pict-UNOS Liver Transplant Registry Clin Transplant 98 1998 17 37
2. Mutimer D. Long term outcome of liver transplantation for viral hepatitis: Is there a need to re-evaluate patient selection? Gut 45 1999 475 476
3. Casino C. Lilli D. Rivanera D. Sabrina C. Rossi M. Casolaro G. Recurrence of hepatitis C virus infection after orthotopic liver transplantation: role of genotypes N Microbiol 22 1999 11 18
4. Tisone G. Baiocchi L. Orlando G. Palmieri G.P. Pisani F. Rapicetta M. Hepatitis C reinfection after liver Transplantation in relation to virus genotype Transplant Proc 31 1999 490 491
5. Prieto M. Berenguer M. Rayon J.M. Cordoba J. Arguello L. Carrasco D. High incidence of allograft cirrhosis in hepatitis C virus genotype 16 infection following transplantation: Relationship with rejection episodes Hepatology 29 1999 250 256
6. Charlton M. Seaberg E. Wiesner R. Everhart J. Zetterman R. Lake J. Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 1998 823 830
7. Herrero J.I. de la Pena A. Quiroga J. Sangro B. Garcia N. Sola I. Risk factors for recurrence of hepatitis C after liver transplantation Liver Transplant Surg 4 1998 265 270
8. Zein N.N. Rakela J. Poterucha J.J. Steers J.L. Wiesner R.H. Persing D.H. Hepatitis C genotypes in liver transplant recipients: Distribution and 1-year follow-up Liver Transplant Surg 1 1995 354 357
9. Gordon F.D. Poterucha J.J. Germer J. Zein N.N. Batts K.P. Gross J.B. Jr Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation Transplantation 63 1997 1419 1423
10. Aardema K.L. Nakhleh R.E. Terry L.K. Burd E.M. Ma C.K. Moonka D.K. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants Mod Pathol 12 1999 1043 1049
11. Dickson R.C. Mizokami M. Orito E. Qian K.R. Lau J.Y. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C-Clinical andvirologic implications Transplantation 68 1999 1512 1516
12. Costes V. Durand L. Pageaux G.P. Ducos J. Mondain A.M. Picot M.C. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome ofrecurrent hepatitis C Am J Clin Pathol 111 1999 252 258
13. Thursz M.R. Kwiatkowski D. Allsopp C.E. Greenwood B.M. Thomas H.C. Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia N Engl J Med 332 1995 1065 1069
14. Thursz M.R. Thomas H.C. Greenwood B.M. Hill A.V. Heterozygote advantage for HLA class-11 type in hepatitis B virus infection Nat Genet 17 1997 11 12
15. Bellamy R. Ruwende C. Corrah T. McAdam K.P. Thursz M. Whittle H.C. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene J Infect Dis 179 1999 721 724
16. [letter] Mead R. Jack D. Pembrey M. Tyfield L. Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood Lancet 349 1997 1669 1670
17. Summerfield J.A. Sumiya M. Levin M. Turner M.W. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series BMJ 314 1997 1229 1232
18. McBride M.O. Fischer P.B. Sumiya M. McClure M.O. Turner M.W. Skinner C.J. Mannose-binding protein in HIV seropositive patients does not contribute to disease progression or bacterial infections Int J STD AIDS 9 1998 683 688
19. Bellamy R. Ruwende C. McAdam K.P. Thursz M. Sumiya M. Summerfield J. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans QJM 91 1998 13 18
20. McGlynn K.A. Rosvold F.A. Lustbader E.D. Hu Y. Clapper M.L. Zhou T. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 Proc Natl Acad Sci USA 92 1995 2384 2387
21. Peano G. Menardi G. Ponzetto A. Fenoglio L.M. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 154 1994 2733 2736
22. Zavaglia C. Bortolon C. Ferrioli G. Rho A. Mondazzi L. Botelli R. HLA typing in chronic type B, D and C hepatitis J Hepatol 24 1996 658 665
23. Zavaglia C. Martinetti M. Silini E. Bottelli R. Daielli C. Asti M. Association between HLA class 11 alleles and protection from or susceptibility to chronic hepatitis C J Hepatol 28 1998 1 7
24. Minton E.J. Smillie D. Neal K.R. Irving W.L. Underwood J.C. James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group J Infect Dis 178 1998 39 44
25. Asti M. Martinetti M. Zavaglia C. Cuccia M.C. Gusberti L. Tinelli C. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease Hepatology 29 1999 1272 1279
26. Tibbs C.J. Tropical aspects of viral hepatitis. Hepatitis C Trans Royal Soc Trop Med Hyg 91 1997 121 124
27. Hohler T. Kruger A. Gerken G. Schneider P.M. Meyer zum Buschenfelde K.H. Rittner C. Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection J Med Virol 54 1998 173 177
28. Till H. Wilmer A. Vogel W. Herold M. Nolchen B. Judmaier G. Serum levels of Cyoknes in chronic liver diseases Gastroenterology 103 1992 264 274
29. Nelson D.R. Lim H.L. Marousis C.G. Fang J.W. Davis G.L. Shen L. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection Dig Dis Sci 42 1997 2487 2494
30. Larrea E. Garcia N. Qian C. Civeira M.P. Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C Hepatology 23 1996 210 217
31. Friedman S.L. Cytokines and fibrogenesis Semin Liver Dis 19 1999 129 140
32. Hurme M. Lahdenpohja N. Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases Ann Med 30 1998 469 473
33. Knight J.C. Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease Proc Assoc Am Physicians 111 1999 290 298
34. Wilson A.G. Symons J.A. McDowell T.L. McDevitt H.O. Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Nail Acad Sci USA 94 1997 3195 3199
35. Rosen H.R. Lentz J.J. Rose S.L. Rabkin J. Corless C.L. Taylor K. Donor polymorphism of tumor necrosis factor gene Transplantation 68 1999 1898 1902
36. Czaja A.J. Cookson S. Constantini P.K. Clare M. Underhill J.A. Donaldson P.T. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis Gastroenterology 117 1999 645 652